Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2012
Imaging apoptosis with positron emission tomography: 'bench to bedside' development of the caspase-3/7 specific radiotracer [(18)F]ICMT-11
Quang-Dé Nguyen, Amarnath Challapalli, Graham Smith, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2026
Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385]
Wiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
The British Journal of Radiology
|
May 11, 2024
Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands
Mitesh Naik, Sairah R Khan, Valerie Lewington, et al.
Biomarkers in Medicine
|
March 28, 2012
Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [(18)F] 3´-deoxy-3´-fluorothymidine PET: a pilot study
Kaiyumars Contractor, Eric O Aboagye, Jimmy Jacob, et al.
Journal of Clinical Pathology
|
June 5, 2015
Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer
Amarnath Challapalli, Sebastian Trousil, Steve Hazell, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
November 21, 2024
PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects
Laszlo K Szidonya, Tara D Barwick, Amarnath Challapalli, et al.
BJU International
|
April 27, 2026
A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer
Syed A Hussain, Amarnath Challapalli, Simran Gill, et al.
Frontiers in Immunology
|
July 29, 2024
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
Amarnath Challapalli, Grant Stewart, Heather Shaw, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 27, 2022
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
Gary J R Cook, Wai-Lup Wong, Bal Sanghera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2014
Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers
Amarnath Challapalli, Rohini Sharma, William A Hallett, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2012
Imaging apoptosis with positron emission tomography: 'bench to bedside' development of the caspase-3/7 specific radiotracer [(18)F]ICMT-11
Quang-Dé Nguyen, Amarnath Challapalli, Graham Smith, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2026
Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385]
Wiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
The British Journal of Radiology
|
May 11, 2024
Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands
Mitesh Naik, Sairah R Khan, Valerie Lewington, et al.
Biomarkers in Medicine
|
March 28, 2012
Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [(18)F] 3´-deoxy-3´-fluorothymidine PET: a pilot study
Kaiyumars Contractor, Eric O Aboagye, Jimmy Jacob, et al.
Journal of Clinical Pathology
|
June 5, 2015
Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer
Amarnath Challapalli, Sebastian Trousil, Steve Hazell, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
November 21, 2024
PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects
Laszlo K Szidonya, Tara D Barwick, Amarnath Challapalli, et al.
BJU International
|
April 27, 2026
A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer
Syed A Hussain, Amarnath Challapalli, Simran Gill, et al.
Frontiers in Immunology
|
July 29, 2024
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
Amarnath Challapalli, Grant Stewart, Heather Shaw, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 27, 2022
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
Gary J R Cook, Wai-Lup Wong, Bal Sanghera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2014
Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers
Amarnath Challapalli, Rohini Sharma, William A Hallett, et al.
Page
of 4